Eton Pharmaceuticals Inc.

ETON | NASDAQ

Price Alert Chart Builder DCF Calculator

$56.79

+$1.48 (+2.68%)

Sep 22, 2026, 11:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	105.6M	86.93M	79.95M	70.32M	58.18M	48.33M	39.01M	34.68M	31.38M	34.3M	31.64M	32.83M	29.02M	24.38M	21.25M	18.85M	16.4M	12.11M	21.83M	15.82M	14.88M	11.84M
Cost of Revenue	44.49M	39.32M	37.21M	34.2M	23.62M	20.06M	15.6M	14.11M	12.72M	11.58M	10.58M	9.04M	7.61M	8.04M	6.8M	4.94M	4.36M	1.75M	2.62M	2.64M	1.88M	1.77M
Gross Profit	61.1M	47.61M	42.74M	36.12M	34.56M	28.27M	23.41M	20.57M	18.67M	22.72M	21.06M	23.79M	21.41M	16.34M	14.45M	13.9M	12.04M	10.36M	19.21M	13.18M	13M	10.06M
Operating Income	16.31M	2.04M	-844K	-2.68M	-807K	-2.27M	-2.6M	-5.22M	-6.28M	542K	-1.19M	1.86M	-484K	-5.71M	-8.26M	-8.01M	-10.96M	-11.95M	-1.5M	-10.23M	-10.65M	-12.87M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2K	2K	2K
Pretax Income	12.75M	-1.49M	-4.56M	-6.48M	-4.03M	-4.5M	-3.81M	-5.31M	-6.39M	1.16M	-689K	2.23M	-234K	-6.35M	-9.02M	-8.89M	-11.94M	-12.4M	-1.96M	-10.68M	-11.09M	-13.81M
Net Income	12.69M	-1.48M	-4.6M	-6.68M	-4.13M	-4.58M	-3.82M	-5.48M	-6.69M	913K	-936K	2.23M	-234K	-6.35M	-9.02M	-8.89M	-11.94M	-12.4M	-1.96M	-10.68M	-11.09M	-13.81M
Selling & General & Admin	39.03M	37.1M	35.82M	33.68M	30.86M	26.77M	22.75M	20.61M	19.66M	18.74M	18.93M	18.71M	18.54M	19.13M	18.71M	18.18M	17.34M	15.34M	14.47M	14.45M	14.55M	14.21M
Research & Development	5.76M	8.48M	7.77M	5.11M	4.51M	3.77M	3.26M	5.17M	5.28M	3.44M	3.32M	3.22M	3.35M	2.91M	4M	3.73M	5.67M	6.97M	6.24M	8.96M	9.1M	8.72M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	44.79M	45.57M	43.58M	38.8M	35.37M	30.53M	26.01M	25.78M	24.94M	22.18M	22.25M	21.93M	21.89M	22.04M	22.71M	21.91M	23M	22.31M	20.7M	23.41M	23.66M	22.93M
Interest Expense	504K	2.78M	4.78M	4.91M	3.7M	2.56M	1.4M	432K	455K	527K	642K	537K	656K	750K	867K	886K	983K	1M	1.01M	1M	985K	940K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	89.29M	84.89M	80.79M	73M	58.99M	50.59M	41.61M	39.9M	37.66M	33.76M	32.83M	30.96M	29.5M	30.09M	29.51M	26.85M	27.36M	24.06M	23.33M	26.05M	25.54M	24.7M
Income Tax Expense	63K	-11K	43K	199K	101K	89K	15K	175K	301K	247K	247K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	27.44M	27.29M	26.91M	26.89M	26.89M	26.89M	26.14M	25.9M	25.78M	25.76M	25.74M	25.72M	25.59M	25.53M	25.38M	25.37M	25.13M	25.3M	25.29M	25.28M	25.2M	24.45M
Shares Outstanding (Diluted)	32.3M	31.55M	26.91M	26.89M	26.89M	26.89M	26.14M	26.55M	25.78M	25.76M	25.74M	25.72M	25.98M	25.53M	25.69M	25.37M	25.13M	25.3M	25.96M	25.28M	25.21M	26.55M
EPS (Basic)	0.47	-0.05	-0.17	-0.25	-0.15	-0.18	-0.15	-0.21	-0.26	0.04	-0.04	0.09	-0.02	-0.26	-0.37	-0.37	-0.48	-0.50	-0.07	-0.43	-0.50	-0.65
EPS (Diluted)	0.38	-0.06	-0.17	-0.25	-0.15	-0.18	-0.15	-0.22	-0.26	0.04	-0.04	0.09	-0.02	-0.26	-0.37	-0.37	-0.48	-0.50	-0.09	-0.45	-0.52	-0.67
EBITDA	15.28M	5.45M	4.27M	472K	993K	-1.35M	-2.59M	-4.95M	-6.1M	1.41M	-341K	3.6M	1.23M	-3.8M	-6.38M	-6.35M	-9.39M	-10.91M	-487K	-9.2M	-9.54M	-12.22M
EBIT	2.61M	1.29M	223K	-2.91M	-1.66M	-3.27M	-3.74M	-6.02M	-7.08M	542K	-1.19M	2.77M	422K	-5.6M	-8.15M	-8.01M	-10.96M	-11.4M	-949K	-9.68M	-10.11M	-12.87M
Depreciation & Amortization	2.03M	4.16M	4.04M	3.38M	2.65M	1.93M	1.15M	1.07M	979K	872K	851K	828K	807K	1.81M	1.77M	1.66M	1.57M	488K	462K	486K	565K	644K